Literature DB >> 8476725

Complement and glomerulonephritis--an update.

R H McLean1.   

Abstract

The complement (C) system in man and its relationship to disease has been the subject of intensive research. In this review, we update the information concerning the nature of the various C components, and present some of the similarities between structure and function of the C components and their respective genes. The clinical problems which are encountered in individuals with acquired C abnormalities and with a genetically determined deficiency of a single component provide helpful clues to understanding the affected patients and the possible functional importance of the particular deficient component. The steady progress in identifying both normal variants of C components and the gene defects which produce C deficiencies offers the prospect of correlating structure of the C components with possible pathogenic roles in disease. Genetically determined C abnormalities are more commonly recognized during childhood. An appreciation of the basic aspects of the C system is a helpful tool for the pediatric nephrologist.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476725     DOI: 10.1007/bf00864413

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  63 in total

1.  SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

Authors:  C D WEST; J D NORTHWAY; N C DAVIS
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  Factor B reference typing report.

Authors:  G Geserick; M Abbal; M Brenden; M Braun-Stilwell; G Mauff; H Schröder; I Siemens
Journal:  Complement Inflamm       Date:  1990

3.  Shunt nephritis: the nature of the serum cryoglobulins and their relation to the complement profile.

Authors:  C F Strife; B M McDonald; E J Ruley; A J McAdams; C D West
Journal:  J Pediatr       Date:  1976-03       Impact factor: 4.406

Review 4.  The role of complement and its receptor in the elimination of immune complexes.

Authors:  J A Schifferli; Y C Ng; D K Peters
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

5.  Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.

Authors:  W S Varade; J Forristal; C D West
Journal:  Am J Kidney Dis       Date:  1990-09       Impact factor: 8.860

6.  C4A deficiency and poor prognosis in patients with IgA nephropathy.

Authors:  R J Wyatt; B A Julian; S Y Woodford; C Wang; J Roberts; J S Thompson; M J Christenson; R H McLean
Journal:  Clin Nephrol       Date:  1991-07       Impact factor: 0.975

7.  Complement phenotypes in glomerulonephritis: increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura.

Authors:  R H McLean; R J Wyatt; B A Julian
Journal:  Kidney Int       Date:  1984-12       Impact factor: 10.612

8.  Membranoproliferative glomerulonephritis in dogs with a genetically determined deficiency of the third component of complement.

Authors:  L C Cork; J M Morris; J L Olson; S Krakowka; A J Swift; J A Winkelstein
Journal:  Clin Immunol Immunopathol       Date:  1991-09

9.  Polymorphism of human c5.

Authors:  M J Hobart; M A vaz Guedes; P J Lachmann
Journal:  Ann Hum Genet       Date:  1981-02       Impact factor: 1.670

10.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05
View more
  1 in total

1.  The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells.

Authors:  A Fayyazi; O Scheel; T Werfel; S Schweyer; M Oppermann; O Götze; H J Radzun; J Zwirner
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.